| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACER2
|
alkaline ceramidase 2
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM22
|
ADAM metallopeptidase domain 22
|
|
ADAMDEC1
|
ADAM-like, decysin 1
|
|
ADAMTS18
|
ADAM metallopeptidase with thrombospondin type 1 motif, 18
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
AP1AR
|
adaptor-related protein complex 1 associated regulatory protein
|
|
APOA1
|
apolipoprotein A-I
|
|
APOD
|
apolipoprotein D
|
|
ARHGAP6
|
Rho GTPase activating protein 6
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ARHGDIG
|
Rho GDP dissociation inhibitor (GDI) gamma
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
B4GALNT2
|
beta-1,4-N-acetyl-galactosaminyl transferase 2
|
|
BCAS3
|
breast carcinoma amplified sequence 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BTLA
|
B and T lymphocyte associated
|
|
BTN2A2
|
butyrophilin, subfamily 2, member A2
|
|
C10ORF54
|
chromosome 10 open reading frame 54
|
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1
|
|
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CBLL1
|
Cbl proto-oncogene-like 1, E3 ubiquitin protein ligase
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
|
CCM2L
|
cerebral cavernous malformation 2-like
|
|
CD164
|
CD164 molecule, sialomucin
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD300A
|
CD300a molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DACT2
|
dishevelled-binding antagonist of beta-catenin 2
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DMTN
|
dematin actin binding protein
|
|
DSCAM
|
Down syndrome cell adhesion molecule
|
|
DSCAML1
|
Down syndrome cell adhesion molecule like 1
|
|
DTX1
|
deltex 1, E3 ubiquitin ligase
|
|
DUSP3
|
dual specificity phosphatase 3
|
|
EPB41L5
|
erythrocyte membrane protein band 4.1 like 5
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
FOXJ1
|
forkhead box J1
|
|
FOXP3
|
forkhead box P3
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
FZD4
|
frizzled class receptor 4
|
|
FZD7
|
frizzled class receptor 7
|
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLMN
|
glomulin, FKBP associated protein
|
|
GTPBP4
|
GTP binding protein 4
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLX
|
H2.0-like homeobox
|
|
HOXA7
|
homeobox A7
|
|
HRG
|
histidine-rich glycoprotein
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNL1
|
interferon, lambda 1
|
|
IHH
|
indian hedgehog
|
|
IL10
|
interleukin 10
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL20RB
|
interleukin 20 receptor beta
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IRF1
|
interferon regulatory factor 1
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGB1BP1
|
integrin beta 1 binding protein 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JAM2
|
junctional adhesion molecule 2
|
|
KANK1
|
KN motif and ankyrin repeat domains 1
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KNG1
|
kininogen 1
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAMB1
|
laminin, beta 1
|
|
LAX1
|
lymphocyte transmembrane adaptor 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LPXN
|
leupaxin
|
|
LRRC32
|
leucine rich repeat containing 32
|
|
MAD2L2
|
MAD2 mitotic arrest deficient-like 2 (yeast)
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5
|
|
MIA3
|
melanoma inhibitory activity family, member 3
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC22
|
mucin 22
|
|
MYADM
|
myeloid-associated differentiation marker
|
|
MYO1F
|
myosin IF
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NDFIP1
|
Nedd4 family interacting protein 1
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKBID
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta
|
|
NOTCH1
|
notch 1
|
|
NRARP
|
NOTCH-regulated ankyrin repeat protein
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PELI1
|
pellino E3 ubiquitin protein ligase 1
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PLET1
|
placenta expressed transcript 1
|
|
PLG
|
plasminogen
|
|
PLXNB1
|
plexin B1
|
|
PLXNB3
|
plexin B3
|
|
PODXL
|
podocalyxin-like
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRNP
|
prion protein
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RC3H1
|
ring finger and CCCH-type domains 1
|
|
RCC2
|
regulator of chromosome condensation 2
|
|
RGCC
|
regulator of cell cycle
|
|
RND1
|
Rho family GTPase 1
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SFTPD
|
surfactant protein D
|
|
SHH
|
sonic hedgehog
|
|
SIPA1
|
signal-induced proliferation-associated 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOCS5
|
suppressor of cytokine signaling 5
|
|
SOCS6
|
suppressor of cytokine signaling 6
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPOCK1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TBCD
|
tubulin folding cofactor D
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
THBS1
|
thrombospondin 1
|
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains
|
|
TIPE2
|
TNF alpha induced protein 8 like 2
|
|
TNC
|
tenascin C
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNR
|
tenascin R
|
|
UBASH3B
|
ubiquitin associated and SH3 domain containing B
|
|
VSIG4
|
V-set and immunoglobulin domain containing 4
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
XCL1
|
chemokine (C motif) ligand 1
|
|
ZC3H8
|
zinc finger CCCH-type containing 8
|
|
ZNF703
|
zinc finger protein 703
|